rs144007479
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_020223.4(FAM20C):c.1218T>A(p.Pro406=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0282 in 1,536,036 control chromosomes in the GnomAD database, including 730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 64 hom., cov: 33)
Exomes 𝑓: 0.028 ( 666 hom. )
Consequence
FAM20C
NM_020223.4 synonymous
NM_020223.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Genes affected
FAM20C (HGNC:22140): (FAM20C golgi associated secretory pathway kinase) This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 7-255994-T-A is Benign according to our data. Variant chr7-255994-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 504906.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.5 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0262 (3989/152290) while in subpopulation NFE AF= 0.0315 (2142/68012). AF 95% confidence interval is 0.0304. There are 64 homozygotes in gnomad4. There are 1841 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 64 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM20C | NM_020223.4 | c.1218T>A | p.Pro406= | synonymous_variant | 6/10 | ENST00000313766.6 | NP_064608.2 | |
FAM20C | XR_007060117.1 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM20C | ENST00000313766.6 | c.1218T>A | p.Pro406= | synonymous_variant | 6/10 | 1 | NM_020223.4 | ENSP00000322323 | P1 | |
FAM20C | ENST00000515795.1 | n.875T>A | non_coding_transcript_exon_variant | 3/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0262 AC: 3993AN: 152172Hom.: 65 Cov.: 33
GnomAD3 genomes
AF:
AC:
3993
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0225 AC: 3159AN: 140380Hom.: 34 AF XY: 0.0218 AC XY: 1641AN XY: 75352
GnomAD3 exomes
AF:
AC:
3159
AN:
140380
Hom.:
AF XY:
AC XY:
1641
AN XY:
75352
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0285 AC: 39386AN: 1383746Hom.: 666 Cov.: 32 AF XY: 0.0279 AC XY: 19059AN XY: 682822
GnomAD4 exome
AF:
AC:
39386
AN:
1383746
Hom.:
Cov.:
32
AF XY:
AC XY:
19059
AN XY:
682822
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0262 AC: 3989AN: 152290Hom.: 64 Cov.: 33 AF XY: 0.0247 AC XY: 1841AN XY: 74470
GnomAD4 genome
AF:
AC:
3989
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
1841
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2016 | p.Pro406Pro in exon 6 of FAM20C: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 3.57% (215/6028) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs144007479). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at